Roger Connor
Vorsitzender bei International Federation of Pharmaceutical Manufacturers
Vermögen: 4 Mio $ am 31.05.2024
Profil
Roger Connor is currently the Chairman of the International Federation of Pharmaceutical Manufacturers.
He is also a Director at Beecham SA, GlaxoSmithKline Consumer Healthcare Pte Ltd., and the Global Alliance on Vaccines & Immunization.
Previously, he was a Director at Human Genome Sciences, Inc. and the President of Vaccines & Global Health at GSK Plc.
He was also the President of GSK Vaccines.
Mr. Connor has an undergraduate degree from Queen's University of Belfast and a graduate degree from the University of Cambridge.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
GSK PLC
0,00% | 12.01.2023 | 176 108 ( 0,00% ) | 4 Mio $ | 31.05.2024 |
Aktive Positionen von Roger Connor
Unternehmen | Position | Beginn |
---|---|---|
GlaxoSmithKline Consumer Healthcare Pte Ltd.
GlaxoSmithKline Consumer Healthcare Pte Ltd. Food: Major DiversifiedConsumer Non-Durables Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Pte Ltd. is a Singaporean company that manufactures and distributes healthcare foods, drugs, pharmaceuticals, and dairy products. The company is based in Singapore, Singapore. | Direktor/Vorstandsmitglied | 01.04.2017 |
Beecham SA
Beecham SA Pharmaceuticals: MajorHealth Technology Founded in 1955, Beecham SA is a Belgian pharmaceutical company that manufactures drugs. The company is based in Wavre, Belgium and is a part of GSK Plc. | Direktor/Vorstandsmitglied | 19.06.2020 |
Global Alliance on Vaccines & Immunization
Global Alliance on Vaccines & Immunization Medical/Nursing ServicesHealth Services Global Alliance on Vaccines & Immunization (Gavi) is an international organization that was established in 2000. Gavi's headquarters are located in Geneva, Switzerland, and it operates in over 70 countries worldwide. The organization's main objective is to enhance access to new and underused vaccines for children residing in the poorest countries worldwide. | Direktor/Vorstandsmitglied | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Vorsitzender | - |
Ehemalige bekannte Positionen von Roger Connor
Unternehmen | Position | Ende |
---|---|---|
GSK PLC | Corporate Officer/Principal | 01.12.2022 |
GSK Vaccines | Präsident | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Roger Connor
University of Cambridge | Graduate Degree |
Queen's University of Belfast | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GSK PLC | Health Technology |
Private Unternehmen | 6 |
---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
Beecham SA
Beecham SA Pharmaceuticals: MajorHealth Technology Founded in 1955, Beecham SA is a Belgian pharmaceutical company that manufactures drugs. The company is based in Wavre, Belgium and is a part of GSK Plc. | Health Technology |
GlaxoSmithKline Consumer Healthcare Pte Ltd.
GlaxoSmithKline Consumer Healthcare Pte Ltd. Food: Major DiversifiedConsumer Non-Durables Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Pte Ltd. is a Singaporean company that manufactures and distributes healthcare foods, drugs, pharmaceuticals, and dairy products. The company is based in Singapore, Singapore. | Consumer Non-Durables |
Global Alliance on Vaccines & Immunization
Global Alliance on Vaccines & Immunization Medical/Nursing ServicesHealth Services Global Alliance on Vaccines & Immunization (Gavi) is an international organization that was established in 2000. Gavi's headquarters are located in Geneva, Switzerland, and it operates in over 70 countries worldwide. The organization's main objective is to enhance access to new and underused vaccines for children residing in the poorest countries worldwide. | Health Services |
GSK Vaccines |